9 10 Convergent evolution describes the process of different populations acquiring similar phenotypes or 11 genotypes. Complex organisms with large genomes only rarely and only under very strong selection 12 converge to the same genotype. In contrast, independent virus populations with very small genomes 13 often acquire identical mutations. Here we test the hypothesis of whether convergence in early HIV-1 14 infection is common enough to serve as an indicator for selection. To this end, we measure the number 15 of convergent mutations in a well-studied dataset of full-length HIV-1 env genes sampled from HIV-1 16 infected individuals during early infection. We compare this data to a neutral model and find an 17 excess of convergent mutations. Convergent mutations are not evenly distributed across the env gene, 18 but more likely to occur in gp41, which suggests that convergent mutations provide a selective 19 advantage and hence are positively selected for. In contrast, mutations that are only found in an HIV-20 1 population of a single individual are significantly affected by purifying selection. Our analysis 21 suggests that comparisons between convergent and private mutations with neutral models allow us to 22 identify positive and negative selection in small viral genomes. Our results also show that selection 23 significantly shapes HIV-1 populations even before the onset of the adaptive immune system. 24 25
evolves and acquires a large number of mutations (Shankarappa et al. 1999; Lemey et al. 2006 ; Keele diversification rates correlate with set point viral load, a disease parameter that affects disease severity progression and strong selection has been shown to correlate with slower disease progression 
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Convergent mutations are unlikely under a neutral model of evolution 116 We observed convergent evolution for a large number of the 1059 mutations identified in the Keele and 117 Li datasets (Figure 1, Supplementary Data 1, Supplementary Data 2) . Mutations occurring in three 118 or more populations in parallel are overrepresented in the dataset (compared to 1000 random 119 distributions of the same number and identical substitution rates as observed in the data, 120 Supplementary Figure 1, Figure 1 ). Mutations occurring in more than five HIV-1 populations in 121 parallel fit particularly badly to the neutral model. The number of convergent mutations declines linear 122 on a log scale for the neutral model. We do not see a linear decline for the Keele and Li data. Instead 123 the decline levels off for highly convergent mutations (Figure 1) . For example, there is one mutation 124 that occurs in seven individuals in parallel, the likelihood to observe this in a neutral model is about 125 0.001. For lower levels of convergence the deviation between neutral model and observation is still 126 significant. For example, in our simulations we observe on average one mutation that occurs in four mutations is still high and it is still possible that residual or low APOBEC activity has caused some of 143 these mutations. To test this hypothesis we analyzed the mutations that occur in all hypermutated 144 sequences (sequences that contain four or more mutations) of the entire dataset. Only 30 HIV 145 populations contain sequences with four or more mutations. The mutations in these sequences are 146 predominantly G to A mutations (65% compared to 36% in the data lacking hypermutated sequences).
147
Despite the low number of HIV populations that contain hypermutated sequences, mutations are shared 148 in this dataset. The most common mutation occurs in nine HIV populations and is also the most 149 common mutation in the dataset lacking hypermutated sequences (G7668A). The next two most common mutations occur in four HIV populations in parallel, one of them also occurs in the dataset HIV populations Number of Nuc. Mutations hypermutated sequences. Of these six mutations, three occur in the hypermutated dataset in two or 153 more HIV populations. If we exclude those three mutations as these may still be the result of residual 154 APOBEC activity then there are seven mutations that are likely the result of positive selection. Among 155 these seven mutations three are G to A mutations. Observing three or more G to A mutations is a very 156 likely outcome of a sampling experiment when using the observed substitution rates (6551 out of 157 10,000 trials, p=0.6551). 
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Convergent mutations occur predominantly in gp41 177 Convergent mutations are also differently distributed across the env gene compared to mutations that 178 only occur in a single HIV-1 population (private mutations). Convergent mutations are more likely to 179 be located at the end of the env gene (Figure 2) . Private mutations are relatively evenly distributed 180 across the entire env gene. The mean of the positions of private mutations is 439, which is very close to 181 half the length of the env gene (428). However, the mean increases for mutations that occur in more 182 than one HIV-1 population. 
Reversion from E to the database consensus K. When dividing the env gene at every possible position and comparing the number of mutations 189 observed before and after this position then we find, again, that there is not a single position that shows 190 a significant difference between the distribution of mutations for the 5' and 3' end of the gene after 191 adjusting for multiple testing (Figure 2B) . However, mutations that occur in three or more HIV 192 populations show very significant differences in their distribution. We found the largest difference at 
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Private mutations are found significantly more frequently in regions of high diversity
231
Private mutations are mutations that we only see in a single HIV population in our dataset. Ideally 232 these should be a sample of all mutations that occur during the replication of HIV. However, as 233 sequences replicate for more than one generation selection will play a role (see measuring mutation 234 rates literature (Mansky 1996) ). Selection will act because mutations that for example introduce stop 235 codons in the middle of an essential gene will be lost in the next generation. Those kinds of mutations 
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Other than the location of mutations across the gene we can also measure nucleotide diversity at each 241 site in the env gene. We measure nucleotide diversity in an alignment of all 95 different consensus 242 sequences. For these measures we do not take the mutations that we have observed in the Keele and Li 243 data into account. For comparison to a neutral model, we randomly distribute mutations across the 244 entire env gene and measure the mean diversity across all 770 positions. Interestingly the mean 245 diversity of randomly distributed mutations in 1000 independent simulations was always lower than the 246 mean diversity at the positions, at which the Keele and Li mutations occurred (Figure 4) . This means 247 that mutations do not occur in low diversity regions in the Keele and Li data. We propose that this 248 pattern is caused by purifying selection, i.e. when mutations occur at low diversity sites they cause 249 strongly deleterious or lethal phenotypes that will not leave offspring in the viral population and hence 250 will be underrepresented in the Keele and Li dataset.
252
Non-synonymous private mutations occur in highly diverse regions of the env gene
253
The significantly higher proportion of synonymous mutations does not cause the significantly higher 254 nucleotide diversity for private mutations. We can understand the causal relationship by comparing the 
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If we set the proportion of synonymous sites in one of our random simulations to the value observed in 276 the Keele and Li data then the nucleotide diversity increases only slightly from 0.217 to 0.221 (purple 277 line in Figure 5 ). If we instead increase the diversity of non-synonymous mutations to that observed in 278 the Keele and Li data, then the mean diversity increases by 0.04, a ten-fold difference in effect size 279 compared to increasing the proportion of synonymous mutations. This demonstrates that the increased 280 proportion of synonymous mutations is not the main driver for the significantly higher nucleotide 281 diversity of private mutations compared to our neutral simulation. Instead, the differences in diversity 282 can be explained by non-synonymous mutations that are more likely to occur at highly diverse sites of 283 the env gene (see also Supplementary Figure 2) .
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If purifying selection is the cause for the observed distribution of non-synonymous mutations then non- 
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Finally, our work also raises the question of why these mutations have not been present in the ancestral 359 strain if they arose in parallel in up to 7% of all subjects. There may be multiple reasons for this 360 phenomenon. First, it is possible that the observed mutations are only beneficial in a small proportion 361 of all hosts. Second, it is possible that the convergent mutations we observed are beneficial during 362 exponential growth but do not confer benefits after the immune response takes effect and hence will be 363 lost during later stages of infection.
365
One could also wonder why there are only few mutations that occur in parallel in few hosts. This may 366 be because mutations that are beneficial in most environments (human hosts) have probably already 
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We defined a mutation as a change from the consensus sequence of the virus population. 
